Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.956 SEK | -1.04% | +7.17% | +38.75% |
Business Summary
Number of employees: 55
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody-based Medicines
100.0
%
| 36 | 100.0 % | 58 | 100.0 % | +62.78% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Finland
100.0
%
| 36 | 100.0 % | 58 | 100.0 % | +62.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Søren Bregenholt
CEO | Chief Executive Officer | 53 | 21-05-31 |
Marie Svensson
DFI | Director of Finance/CFO | 60 | 20-08-31 |
Chief Tech/Sci/R&D Officer | 56 | 22-01-31 | |
Peter Ellmark
CTO | Chief Tech/Sci/R&D Officer | 51 | 17-12-31 |
Chief Tech/Sci/R&D Officer | 42 | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 70 | 16-12-31 | |
Staffan Encrantz
BRD | Director/Board Member | 72 | 22-05-08 |
Director/Board Member | 62 | 21-05-31 | |
Denise Goode
BRD | Director/Board Member | 66 | 22-05-08 |
Director/Board Member | 53 | 21-05-31 | |
Chief Tech/Sci/R&D Officer | 42 | 13-12-31 | |
62 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 949,850 | 0 | 0 | 59.28 % |
Stock B | 1 | 657,954,290 | 390,619,939 ( 59.37 %) | 0 |
Company contact information
Alligator Bioscience AB
Medicon Village Scheelevägen 2
223 81, Lund
+46 4 65 40 82 00
http://www.alligatorbioscience.comGroup companies
Name | Category and Sector |
---|---|
A Bioscience Incentive AB
|
Sector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+38.75% | 69.01M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- ATORX Stock
- Company Alligator Bioscience AB